Peter Dynoodt

771 total citations
12 papers, 432 citations indexed

About

Peter Dynoodt is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Peter Dynoodt has authored 12 papers receiving a total of 432 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in Peter Dynoodt's work include Breast Cancer Treatment Studies (5 papers), Advancements in Transdermal Drug Delivery (2 papers) and Estrogen and related hormone effects (2 papers). Peter Dynoodt is often cited by papers focused on Breast Cancer Treatment Studies (5 papers), Advancements in Transdermal Drug Delivery (2 papers) and Estrogen and related hormone effects (2 papers). Peter Dynoodt collaborates with scholars based in Ireland, Belgium and United Kingdom. Peter Dynoodt's co-authors include Jo Lambert, Mireille Van Gele, Barbara Geusens, Reinhart Speeckaert, Stefanie Bracke, Niek N. Sanders, Liève Brochez, Olivier De Wever, Inès Chevolet and Jo Vandesompele and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Annals of Oncology.

In The Last Decade

Peter Dynoodt

12 papers receiving 429 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Dynoodt Ireland 7 259 156 112 63 54 12 432
И. В. Коробко Russia 14 330 1.3× 161 1.0× 75 0.7× 76 1.2× 67 1.2× 62 559
Raymonde Hotz Switzerland 11 417 1.6× 130 0.8× 95 0.8× 111 1.8× 157 2.9× 11 603
Peter LaCelle United States 6 171 0.7× 136 0.9× 44 0.4× 101 1.6× 33 0.6× 8 391
Ralph Jans United States 11 189 0.7× 68 0.4× 43 0.4× 48 0.8× 63 1.2× 12 338
Bohee Jang South Korea 9 172 0.7× 159 1.0× 61 0.5× 25 0.4× 17 0.3× 18 315
Ruri Lee South Korea 6 259 1.0× 27 0.2× 130 1.2× 25 0.4× 80 1.5× 7 486
Ulrich Kloz Germany 8 359 1.4× 35 0.2× 38 0.3× 73 1.2× 75 1.4× 13 626
Annalisa Saltari Italy 12 179 0.7× 59 0.4× 39 0.3× 45 0.7× 111 2.1× 17 401
Katherine Sully United Kingdom 9 267 1.0× 95 0.6× 34 0.3× 52 0.8× 104 1.9× 10 542
James T. Elder United States 7 222 0.9× 109 0.7× 23 0.2× 237 3.8× 117 2.2× 8 458

Countries citing papers authored by Peter Dynoodt

Since Specialization
Citations

This map shows the geographic impact of Peter Dynoodt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Dynoodt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Dynoodt more than expected).

Fields of papers citing papers by Peter Dynoodt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Dynoodt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Dynoodt. The network helps show where Peter Dynoodt may publish in the future.

Co-authorship network of co-authors of Peter Dynoodt

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Dynoodt. A scholar is included among the top collaborators of Peter Dynoodt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Dynoodt. Peter Dynoodt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Guttà, Cristiano, Arman Rahman, Claudia Aura, et al.. (2020). Low expression of pro-apoptotic proteins Bax, Bak and Smac indicates prolonged progression-free survival in chemotherapy-treated metastatic melanoma. Cell Death and Disease. 11(2). 124–124. 26 indexed citations
2.
Buus, Richard, Ivana Šestak, Stephen Barron, et al.. (2019). Validation of the OncoMasTR Risk Score in Estrogen Receptor–Positive/HER2-Negative Patients: A TransATAC study. Clinical Cancer Research. 26(3). 623–631. 8 indexed citations
3.
4.
Kelly, Catherine M., John Crown, Stephen Barron, et al.. (2018). Comparison of the prognostic performance between OncoMasTR and OncotypeDX multigene signatures in hormone receptor-positive, HER2-negative, lymph node-negative breast cancer.. Journal of Clinical Oncology. 36(15_suppl). 12074–12074. 1 indexed citations
5.
Loughman, Tony, Peter Dynoodt, Stephen Barron, et al.. (2018). Analytical validation of OncoMasTR, a multigene test for predicting risk of distant recurrence in hormone receptor-positive early stage breast cancer. Annals of Oncology. 29. viii65–viii65. 2 indexed citations
6.
Šestak, Ivana, Richard Buus, Jack Cuzick, et al.. (2018). Evaluation of the OncoMasTR prognostic signature in postmenopausal women with primary ER-positive breast cancer.. Journal of Clinical Oncology. 36(15_suppl). 553–553. 1 indexed citations
7.
Foth, Mona, et al.. (2015). Prognostic and predictive biomarkers in melanoma: an update. Expert Review of Molecular Diagnostics. 16(2). 223–237. 22 indexed citations
8.
Dynoodt, Peter, Reinhart Speeckaert, Olivier De Wever, et al.. (2013). miR-145 overexpression suppresses the migration and invasion of metastatic melanoma cells. International Journal of Oncology. 42(4). 1443–1451. 67 indexed citations
9.
Dynoodt, Peter, Pieter Mestdagh, Gert Van Peer, et al.. (2012). Identification of miR-145 as a Key Regulator of the Pigmentary Process. Journal of Investigative Dermatology. 133(1). 201–209. 94 indexed citations
10.
Geusens, Barbara, Stefanie Bracke, Peter Dynoodt, et al.. (2011). Lipid-mediated gene delivery to the skin. European Journal of Pharmaceutical Sciences. 43(4). 199–211. 84 indexed citations
11.
Bracke, Stefanie, Barbara Geusens, Peter Dynoodt, et al.. (2011). Synthesis and characterization of non-viral liposomal carriers for the local application of siRNA molecules and anti-miRNAs in the therapeutic treatment of psoriasis. Journal of Translational Medicine. 9(S2). 2 indexed citations
12.
Gele, Mireille Van, Peter Dynoodt, & Jo Lambert. (2009). Griscelli syndrome: a model system to study vesicular trafficking. Pigment Cell & Melanoma Research. 22(3). 268–282. 123 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026